COMMUNIQUÉS West-GlobeNewswire

The Dr.Quay.com Website and ElevatorMedicine™ Launch to Promote Breast Cancer Awareness Month

01/10/2019 - 17:00

SEATTLE, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Dr. Steven Quay, MD, PhD, is proud to announce today his participation in National Breast Cancer Awareness Month with the launch of his new website, www.DrQuay.com , dedicated [...]

Cheetah Medical Presents Update on FRESH Clinical Trial at the European Society of Intensive Care Medicine 32nd Annual Congress

01/10/2019 - 17:34

NEWTON, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Cheetah Medical, a medical device leader in non-invasive fluid management technology, presented today at the European Society of Intensive Care Medicine (ESICM) Annual [...]

Single-Inhaler Extrafine Triple Therapy of Inhaled Corticosteroid, Long-Acting B2-Agonist and Long-Acting Muscarinic Antagonist Therapy Improves Lung Function and Reduces Asthma Exacerbations(1)

01/10/2019 - 17:41

Data from two randomized, double-blind, parallel-group, active-controlled studies on the efficacy and safety of single-inhaler triple therapy in adult patients with uncontrolled asthma is published in The Lancet for the [...]

Scilex Announces New Medicaid Agreements with CA & FL

01/10/2019 - 13:00

PALO ALTO, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Scilex Holding Company (Scilex), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE), is excited to announce that its subsidiary, Scilex [...]

Amicus Therapeutics to Present at Upcoming Medical and Investor Conferences in October 2019

01/10/2019 - 13:00

CRANBURY, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced upcoming presentations at the following medical and investor conferences in October. Upcoming Medical Conferences: An [...]

Constellation Pharmaceuticals Announces $65 Million Private Placement with New and Existing Investors

01/10/2019 - 13:00

CAMBRIDGE, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]

Microbix Presenting at StableView TECH19 Conference

01/10/2019 - 13:00

Meetings with Growth-Oriented Investors, October 3, 2019 MISSISSAUGA, Ontario, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix ® ), an innovator of clinical diagnostic materials and [...]

Fulcrum Therapeutics Announces Multiple Presentations of Losmapimod Data at World Muscle Society Meeting

01/10/2019 - 13:00

Oral presentation to highlight Phase 1 data on safety, tolerability and target engagement of losmapimod in treatment of FSHD Company also announces updated preclinical data on FTX-6058 for potential treatment of sickle [...]

CRISPR Therapeutics to Present at Upcoming Investor Conferences

01/10/2019 - 13:00

ZUG, Switzerland and CAMBRIDGE, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]

PDMR Dealing/Issue of Equity

01/10/2019 - 13:14

Cambridge, UK and Indianapolis, US – 1 October 2019: Acacia Pharma Group plc (the "Company), (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea and [...]

CURE Pharmaceutical Promotes Dr. Vered Gigi to Chief Scientific Officer

01/10/2019 - 13:25

Biopharma star brings extensive translational research experience as company advances its clinical indications OXNARD, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug [...]

Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting

01/10/2019 - 13:30

Data from Analysis of Cancer Tissue Proteins Generated from Novel Workflow Could Lead to Improvement in the Clinical Management of Gynecological Cancers SOUTH EASTON, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR [...]

Stemline Therapeutics Recaps Felezonexor (SL-801) Clinical Data Presentation From ESMO 2019 Congress

01/10/2019 - 13:30

NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]

Ocugen Appoints Sanjay S. Subramanian, MBA, as Chief Financial Officer

01/10/2019 - 13:30

MALVERN, Pa., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Ocugen, Inc. , (NASDAQ: OCGN), a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that [...]

AGTC and Otonomy Announce Strategic Collaboration to Develop and Commercialize Gene Therapy for Congenital Hearing Loss

01/10/2019 - 13:30

Initial focus on GJB2, the most common cause of genetic hearing loss in newborns GAINESVILLE, Fla. and CAMBRIDGE, Mass. and SAN DIEGO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: [...]

Minerva Neurosciences Announces Update for Three Clinical Trials

01/10/2019 - 13:30

Company to host conference call at 8:30 a.m. today (dial-in information below) WALTHAM, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company [...]

Helius Medical Technologies to Release Third Quarter of Fiscal Year 2019 Financial Results on November 12, 2019

01/10/2019 - 13:30

NEWTOWN, Pa., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that third [...]

Translate Bio Announces Upcoming MRT5005 Presentations at the 33rd Annual North American Cystic Fibrosis Conference

01/10/2019 - 13:30

LEXINGTON, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]

iCAD Showcases ProFound AI™ Platform at European Society of Breast Imaging Annual Scientific Meeting in Budapest

01/10/2019 - 14:00

Company to exhibit ProFound AI for 2D and 3D Mammography in Europe NASHUA, N.H. and BUDAPEST, Hungary, Oct. 01, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative [...]